Johanna (Hanneke) Jansen, Ph.D.

Dr. Hanneke Jansen is the Head of the Computer-Aided Drug Discovery (CADD) group at the Emeryville site of the Novartis Institutes for BioMedical Research. Her group develops and applies CADD approaches to projects at all stages of the global portfolio to impact drug discovery. Hanneke’s research interests include the design of relevant compound sets for hit generation, improved predictive modeling that leverages large complex datasets, and developing computational chemistry & data-mining methods that can be integrated into state-of-the-art workflows to inform decision-making from target-ID and validation through hit generation and optimization. Prior to Novartis, Hanneke worked at Chiron Corporation and at Astra.

Hanneke is a Fellow of the American Chemical Society and the founder of the Teach-Discover-Treat initiative, which is an initiative to provide high quality computational chemistry tutorials that impact education and drug discovery for neglected diseases. She received her Ph.D. in Computational Medicinal Chemistry from the School of Pharmacy, University of Groningen (Netherlands) and completed a postdoctoral term at the BioMedical Center of Uppsala University (Sweden).

Focus on the patient, follow the science

At the earliest stages of Research, our drug discovery priorities are determined by patient need and sound science – not the potential market size of a medicine.